Yahoo

Is Solvay (ENXTBR:SOLB) Fairly Valued As Rare Earth Expansion Hopes Grow?

Solvay (ENXTBR:SOLB) has drawn investor attention after recent trading left the share price around €25.14, with the stock down over the past week, month and past 3 months.

Recent trading pressure has pulled Solvay's 1-day share price return down 4.41% and left the year-to-date share price return down 8.05%. However, the 3-year total shareholder return of 43.37% suggests longer term holders have still seen meaningful value creation.

Scan other materials stocks facing similar pressure and see how Solvay compares with 183 high quality undervalued stocks in terms of cash flow strength and balance sheet quality.

Solvay's chemicals portfolio still speaks to a sizeable and established business, yet the share price has slipped in recent months. Does that recent weakness leave the stock attractively valued or still expensive on fundamentals?

Most Popular Narrative: 0% Overvalued

Solvay's most followed narrative pegs fair value at €25.10, sitting almost exactly on the recent €25.14 close. This frames the latest share pullback as a valuation reset rather than a clear bargain or premium.

Growing customer demand for rare earth production capacity outside of China, triggered by Chinese export controls and seeking greater supply chain localization, positions Solvay's La Rochelle plant for potential rapid expansion, paving the way for incremental high-value revenue streams and improved asset utilization in the coming years.

See why 31 investors see Solvay as 0% overvalued .

Result: Fair Value of €25.10 (ABOUT RIGHT)

Still, prolonged pricing pressure in soda ash and Coatis, along with ongoing environmental remediation costs, could chip away at the Solvay narrative that investors are watching.

Find out about the key risks to this Solvay narrative .

Another View: What Multiples Say About Solvay

There is a different angle when looking at Solvay through its P/S ratio. The shares trade around 0.6x sales, which is in line with the estimated fair ratio of 0.6x and below the wider European chemicals sector at roughly 1x. That points to limited multiple risk on today's price, although it raises a clear question: if earnings forecasts are this strong while revenue is expected to drift lower, is the market correctly pricing that mix or leaving a gap you need to judge for yourself?

See what the numbers say about this price — find out in our valuation breakdown.

ENXTBR:SOLB P/S Ratio as at Sep 2026
ENXTBR:SOLB P/S Ratio as at Sep 2026

Next Steps

Mixed signals on Solvay so far, with pressure on the recent share performance but a fair value narrative sitting close to the current price. Move quickly to check the underlying data points for yourself and weigh both sides of the story through 3 key rewards and 4 important warning signs

Looking for more ideas beyond Solvay?

If Solvay raises fresh questions about where to put money to work next, widen the search and let data-driven stock lists do the heavy lifting.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SOLB.BR .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: